Skip to main content
Integrative Medicine Research logoLink to Integrative Medicine Research
. 2025 Aug 17;15(1):101228. doi: 10.1016/j.imr.2025.101228

Chlorella vulgaris, a representative edible algae as integrative and alternative medicine

Yein Heo a, Mi-Yeon Kim b,⁎, Jae Youl Cho a,⁎
PMCID: PMC12450572  PMID: 40985044

Abstract

Algae exhibit diverse biological activities, and they are also natural resources with the potential for large-scale production. As a result, research on algae has progressed, and the roles of algae have been revealed. Chlorella vulgaris, one of the species most widely found in East Asian countries such as China, Korea, and Japan, has confirmed diverse functional and pharmacological attributes, leading to extensive consumption of Chlorella vulgaris as a supplement. Seven active compounds extracted from Chlorella vulgaris such as dodecanoic acid and loliolide have been reported to collectively contribute to its overall bioactive and medicinal activities.

Keywords: Chlorella vulgaris, Edible algae, Functional food, Biological activities, Bioactive compounds

1. Introduction

Algae is a generic term that describes photosynthetic organisms. Specifically, algae comprise members from four biological kingdoms: Bacteria, Plantae, Chromista, and Protozoa.1 Algae can be found anywhere on Earth where photosynthesis is possible, from seas, rivers, lakes, and soil to even walls, animals, and plants.2 They can range from unicellular organisms measuring 3–10 μm to massive kelp that can grow to 70 m.3 Therefore, they are roughly classified by size into macroscopic algae, which humans can see with bare eyes, and microscopic algae (phytoplankton), which humans can observe only under a microscope.4 Macroscopic algae include red algae, green algae, and brown algae, which are distinguished by the colors of their chloroplast pigments. The microalgae comprise diverse groups: Chlorophyta (green algae), Bacillariophyta (diatoms), Cyanophyta (blue-green algae or cyanobacteria), Rhodophyta (red algae), and Heterokontophyta (brown algae and some golden algae).5

Chlorella vulgaris is a unicellular green eukaryotic microalga of the Chlorella genus that has existed since the Precambrian era.6 Though it is globally distributed in freshwater, marine water and soil, it can be found easily in the East Asian countries of China, Japan, and Korea.7,8 It is widely consumed in these countries as a functional supplement with numerous health-promoting properties. Furthermore, it has garnered interest in potential applications in cosmetics and bioplastics to take advantage of its natural origins.

Once, people tended to focus on the negative aspects of algae, such as algal blooms. However, the versatility of algae has renewed interest in researching it. As a result, it has been demonstrated that algae exhibit considerable diversity based on their species, with each one possessing distinct biological activities. This review describes how the bioactivities of an alga’s chemical components affect its biological functions, with a specific emphasis on C. vulgaris—a representative microalga extensively studied in East Asia—to understand how chemical composition confers biological activity.

2. Chemical components of algae

2.1. Proteins

Proteins are some of the most biologically and chemically important molecules in all living organisms, serving as structural supports, biochemical catalysts such as hormones and enzymes, and cellular components. Amino acids are the basic units of all proteins, with 50 to 2000 of them linked to a chain and interacting with one another to construct a structure.9 There are 20 amino acids in total, and they are roughly classified as essential and nonessential. The nine essential amino acids are those that cannot be synthesized by animal cells and must therefore be obtained through diet: histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan, and valine. The 11 nonessential amino acids, on the other hand, can be synthesized de novo in animal cells in the amounts required for growth, generation, etc. They include alanine, glycine, and cysteine.

2.1.1. Immune system support

Because amino acids are the basic units of proteins, which are the building blocks of most biological components, amino acids from microalgae support the immune system by providing the materials needed to produce immune-related proteins such as antibodies, cytokines, and complements, which serve as key factors in immunity. In particular, arginine, which is abundant in algae, plays an important role in immune function. Nitric oxide, which is synthesized from arginine, directly removes pathogens as a cytotoxic agent and promotes or inhibits the apoptosis or necrosis of immune cells, depending on the situation.10, 11, 12 It also affects immune cell function by enhancing T cell maturation and increasing the proliferation of CD8 T cells.13 In addition, it lowers the levels of pro-inflammatory cytokines (interleukin-(IL)-2, IL-6, and interferon gamma (IFN-γ)) and increases the levels of an anti-inflammatory cytokine (IL-10) to reduce inflammatory responses.14

2.1.2. Anti-inflammatory and antioxidant properties

Algae contain bioactive compounds that can work as anti-inflammatory and antioxidant agents. These characteristics could be useful for treating chronic diseases such as cardiovascular diseases and diabetes.15 For example, a Porphyra yezoensis glycoprotein showed anti-inflammatory responses in lipopolysaccharide (LPS)-induced macrophages.16 Lectin isolated from Pterocladiella capillacea significantly inhibited neutrophil migration by suppressing inflammatory mediators.17 C-phycocyanin, a biliprotein from Spirulina platensis, repressed inflammation by blocking the generation of pro-inflammatory cytokines and the expression of inducible nitric oxide synthase and cyclooxygenase-2.18

In addition to its anti-inflammatory traits, C-phycocyanin also displayed antioxidant properties for scavenging radical oxidative species such as alkoxy radicals and hydroxyl radicals.19 Schizochytrium limacinum protein hydrolysate has 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical and 2,2′-azino-bis-(3-ethylbenzothiazoline-6-sulfonic) acid (ABTS) radical scavenging abilities. It also showed low-density lipoprotein (LDL) oxidization inhibition activity, which means that it could prevent cardiovascular diseases, especially atherosclerotic diseases.20,21 Protein and hydrolytic extracts from Nitzschia laevis exhibited strong in vitro antioxidant activity, as demonstrated by assays measuring the oxygen radical absorbance capacity and ability to scavenge ABTS radicals, DPPH radicals, and superoxide anion radicals.22

2.1.3. Pharmaceutical applications

The health-promoting properties are also encouraging studies of algal proteins and amino acids for pharmaceutical uses. For example, phycocyanin, a phycobilin protein sourced from Arthronema africanum, Spirulina platensis, and Porphyra haitanensis, is reported to inhibit the proliferation of human hepatocellular carcinoma, lung/colon cancer, and leukemia cells.23 Furthermore, microalgae-based protein from 7 microalgal strains showed good reactivity to target proteins. Moreover, the extracellular vesicles in normal and cancer mammalian cell lines in which those proteins were found exhibited no toxicity, highlighting their potential as a promising platform for drug delivery.24

2.2. Carbohydrates

The foremost role of polysaccharides is to supply and store energy in the body. Polysaccharides are hydrolyzed into monosaccharides and oxidized to provide energy for the body, and monosaccharides can be synthesized into polysaccharides to store energy for future use. Polysaccharides are classified as homopolysaccharides and heteropolysaccharides. Homopolysaccharides are composed of single saccharides, and heteropolysaccharides are composed of two or more different saccharides. Most algal polysaccharides are heteropolysaccharides linking galactose, xylose, and glucose in different ratios by glycosidic bonds.25 Other simple sugars, such as arabinose, mannose, fucose, rhamnose, and 2-O-methyl sugars, and acidic components such as glucuronic acid and galacturonic acid also constitute microalgal polysaccharides.26 Microalgal polysaccharides can be categorized instead by their location in the cell: intracellular and structural polysaccharides. Intracellular polysaccharides act energy reservoirs, whereas structural polysaccharides serve as exopolysaccharides secreted into the medium, cell-bound polysaccharides, and cell wall polysaccharides.26,27 Each microalga has distinctive polysaccharides, and most intracellular polysaccharides accumulate in plastids in the form of starch.28 Meanwhile, the structural polysaccharides, specifically the algal cell wall, are primarily composed of cellulose and hemicellulose.28 Algae thus contain large quantities of carbohydrates that can be transformed into high-value functional foods, animal feed, pharmaceuticals, and health supplements.

2.2.1. Antiviral properties

Among the various types of algal polysaccharides, sulfated polysaccharides are particularly vital to the biological activity of algae. Sulfated polysaccharides are predominantly present in marine algae, rather than terrestrial algae.29 The sulfate group ion cross-links with the backbone of the polysaccharide sugar structure (i.e., the cell wall), imparting a negative charge.30 This characteristic allows the algae to maintain a stable structure under high salinity conditions through mechanical, ionic, and osmotic regulation, supporting their persistence in marine environments.29,30

As the sulfate content in polysaccharides increases, their antiviral activity also increases, demonstrating that sulfate is an important factor in polysaccharide activity against viruses.31 Different types of polysaccharides can block different stages of viral infection. Generally, an early step of the viral replication cycle, especially viral particle adsorption to the host cell surface, is impeded.32 This is the most effective way to interrupt viral invasion.33 To illustrate, the V3 loop of the viral envelope glycoprotein binds to heparan sulfate, a sulfated polysaccharide on the surface of host cells.34 This link is established through an ionic interaction between anionic (mainly sulfate) groups of polysaccharides and the basic amino acids in the viral envelope glycoprotein.35 Consequently, algae can hinder viral penetration by masking the positively charged V3 loop of the virus with its negatively charged sulfated polysaccharides, thereby thwarting host cell attachment.34 A polysaccharide isolated from Porphyridium sp. effectively prevented herpes simplex virus infection in Vero cells both in vitro and in vivo in newborn rats and rabbits.36 Additionally, all extracellular polymeric substance extracts exhibited potent activity against the V. stomatitis virus, surpassing the effectiveness of all tested chemical compounds.37 It was also found that an extracellular polysaccharide extracted and isolated from Porphyridium cruentum inhibited hepatitis B virus in vitro by reducing HBeAg excretion while showing low toxicity to cells.38 Calcium spirulan (Ca-Sp), a sulfated polysaccharide obtained from Spirulina platensis, prevents the replication of various viruses and demonstrates broad-spectrum antiviral potential against influenza virus, human cytomegalovirus, mumps virus, measles virus, and human immunodeficiency virus type 1 (HIV-1).39,40 Ca-SP holds significant promise as a potential anti-HIV agent because it does not enhance virus-induced syncytium formation, even at low concentrations, unlike the effects seen in dextran sulfate–treated cultures.40

2.2.2. Antioxidant activity

Polysaccharides with high sulfate content scavenge reactive oxygen species more effectively than those with low sulfate content, indicating greater antioxidant activity.41,42 Sulfated polysaccharides are superior to de-sulfated polysaccharides in radical scavenging and electron-donating. One mechanism underlying their antioxidant activity is the inhibition of free radical generation through the chelation of ions such as iron and copper. These transition metal ions can catalyze the formation of highly reactive hydroxyl radicals from superoxide and hydrogen peroxide via the Fenton reaction.43 The sulfate group enhances the ability of polysaccharides to form stable chelates with metal ions, thereby elevating the antioxidant effects.43 For example, sulfated polysaccharides from Picochlorum sp. demonstrated exceptionally high antioxidant activity, with 85 % DPPH radical scavenging activity at a concentration of 2 mg/ml. Sulfated polysaccharides from three different strains of Chlorella sp. (Chlorella sorokiniana, Chlorella sp. (L2), and Chlorella sp. (D1)), excluding Chlorella sp. (N4), showed >50 % ABTS radical scavenging activity at 1 mg/ml and about 90 % activity at 2 mg/ml.44 Moreover, aqueous extracellular polysaccharides derived from the Tunisian thermophilic microalga Graesiella sp. acted as powerful reducing agents and ferrous chelating agents, significantly reducing hydroxyl radicals in a concentration-dependent fashion.45

2.2.3. Anticancer activity

Polysaccharides drive the anticancer properties of algae. Ca-Sp, a sulfated polysaccharide isolated from Spirulina platensis, has been found to inhibit pulmonary metastasis and suppress the attachment and growth of tumor cells.46 A cell-wall sulfated polysaccharide (PcrPSH) from Porphyridium cruentum has demonstrated strong anti-tumor effects against Graffi myeloid tumors in hamsters. In vivo, PcrPSH reduced transplant-ability, mortality rates, and tumor growth. In vitro, both in the control group and the group of hamsters transplanted with Graffi myeloid tumors, PcrPSH enhanced the expansion and phagocytic ability of peritoneal macrophages. Additionally, in a primary Graffi tumor cell culture, PcrPSH significantly reduced cell viability, suggesting PcrPSH as a potential new antitumor agent.47

2.3. Lipids

Lipids are divided into two categories: polar and neutral. Lipids are insoluble to water, but they dissolve in most organic solvents. Polar lipids have phospholipids and glycolipids as components, whereas neutral lipids comprise acylglycerides (including tri-, di-, and monoglycerides) and fatty acids.48 Among the diverse bioactive lipids, polyunsaturated fatty acids (PUFAs) are known for their health benefits.49,50 In fact, microalgae are natural resources abundant in PUFAs.51 Due to their bountiful enzymes for very long chain PUFA (VLC-PUFA) synthesis, unlike mammals and seed plants, they can be considered a sustainable resource for VLC-PUFA generation.52 Two principal types of PUFAs are omega-6 and omega-3 fatty acids. Both of them are crucial for human health, and they are synthesized from linoleic acid and linolenic acid, respectively. Alpha-linolenic acid, eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) are the main omega-3 fatty acids, and gamma-linolenic acid and arachidonic acid are notable omega-6 fatty acids.53 Among microalgae-produced PUFAs, DHA and EPA are especially significant due to their high bioactivity and nutritional importance. These PUFAs are synthesized in large quantities due to the demand for their health benefits.54

2.3.1. Anti-inflammatory activity

It has been confirmed that the glycoglycerolipids monogalactosyldiacylglycerol, digalactosyldiacylglycerol, and sulphoquinovosyldiacylglycerol, which were isolated and purified from the blue-green alga ETS-05, exhibit in vivo anti-inflammatory activity. All three compounds dose-dependently inhibited croton oil–induced ear edema in mice. Similarly, in a separate carrageenan-induced paw edema model, these glycoglycerolipids demonstrated a concentration-dependent suppression of inflammation, confirming their anti-inflammatory effects.55

Additionally, lipid extracts from the blue-green algae Nostoc commune var. sphaeroides Kützing and Spirulina platensis (at a concentration of 100 μg/ml) significantly reduced the expression and secretion of pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α), IL-1β, and IL-6 when bone marrow-derived macrophages and splenocytes were pretreated with the extracts and then stimulated with LPS. In RAW264.7 macrophages, lipid extracts from these two algae were found to reduce the nuclear translocation of NF-κB, indicating that their anti-inflammatory activity was mediated by inhibition of the NF-κB pathway.56

In clinical studies, EPA and DHA, alongside antirheumatic drugs, alleviated joint pain in rheumatoid arthritis patients, provided beneficial effects for those with ulcerative colitis, and, when used with medications, reduced the toxicity of cyclosporin in patients suffering from psoriasis.57 Diets enriched with EPA and DHA could produce anti-inflammatory effects by inhibiting the 5-lipoxygenase pathway in neutrophils and monocytes, as well as by preventing leukotriene B4–mediated neutrophil recruitment into the airways.58

2.3.2. Cardiovascular health management

Among the omega-3 fatty acids, EPA and DHA particularly mitigate cardiovascular diseases such as arrhythmia, stroke, and hypertension.59 Omega-3 supplementation has been demonstrated to prevent heart rate variability decline, which is an important index of cardiac autonomic regulation.60 Research reported that administering PUFAs to patients going through coronary artery bypass graft surgery lowered the occurrence of postoperative atrial fibrillation (54.4 %) and hastened discharge from the hospital.61 Moreover, DHA supplements improved the high-density lipoprotein (HDL)/LDL ratio and lowered the total cholesterol/HDL ratio at the same time, indicating diminished risks of coronary artery disease. Those findings elucidated some of the mechanisms by which omega-3 PUFAs contribute to cardiovascular disease reduction.62

2.4. Secondary metabolites

2.4.1. Volatile compounds

Volatile organic compounds (VOCs) easily vaporize under normal conditions.63 VOCs include a wide range of compounds such as terpenoids, sulfur compounds, aromatic compounds, amines, alkanes, alkenes, carbonyls, alcohols, esters, ethers, acids, thiols, ketones, and furans.64, 65, 66, 67 These diverse VOCs are emitted by various organisms in both terrestrial and aquatic ecosystems, including algae.68 VOCs are involved in a range of processes, enhancing resistance to abiotic stress, transmitting information, contributing to allelopathic interactions, and providing protection against predation.69 Nonetheless, VOCs can have both direct and indirect effects on humans, often resulting in harmful impacts ranging from mild irritation to severe health issues such as cancer.70 Most VOC emissions stem from the massive emissions of anthropogenic processes; the small quantities produced by natural sources such as algae are not enough to cause adverse effects in humans.63 In a study that exposed 62 subjects to an indoor air pollutant mixture of 22 VOCs at a maximum concentration of 25 mg/m³, everyone remained healthy, and except for a few who experienced mild symptoms of dry mucous membranes in the eyes, nose, or upper airways, no one exhibited symptoms of asthma, allergy, or chronic bronchitis.71 Therefore, consuming moderate amounts of algae poses no threat of harm. Although research on the role of VOCs in algae is still in the early stages, this review describes some potential uses for algal VOCs.72

2.4.1.1. Antioxidant activity

Zuo Z et al. revealed that under acetic acid stress, Chlamydomonas cells secrete biogenic VOCs that upregulate the activity of the antioxidant enzymes superoxide dismutase, peroxidase, and catalase.72 In another instance, limonene, a type of terpene more precisely classified as a monocyclic monoterpene hydrocarbon, was quantified in six algal species: Desertifilum spp., Spirulina sp., Scenedesmus obliquus, C. vulgaris, C. sorokiniana, and Scenedesmus bijuga.73,74 Limonene not only lowered the H₂O₂ levels in lymphocytes by elevating the activity of catalase and peroxidase, but also protected the cells from oxidative stress caused by the external addition of H₂O₂.75 This suggests that limonene has the potential to protect lymphocytes from oxidative stress–related diseases, including cancer.75

2.4.1.2. Antimicrobial activity

Terpenes are known to display antimicrobial properties against both antibiotic-susceptible and antibiotic-resistant bacteria. Their effectiveness primarily arises from their ability to induce cell rupture, bacterial homeostasis alteration, and the inhibition of protein and DNA synthesis.76 Limonene, a type of terpene, demonstrates synergistic effects when combined with gentamicin antibiotics, improving the inhibition of Gram-positive Staphylococcus aureus, Gram-negative Escherichia coli, and several antibiotic-resistant bacteria.77 Moreover, the pairing of limonene and ε-polylysine produced an additive and beneficial synergistic effect against E. coli, S. aureus, Bacillus subtilis, and Saccharomyces cerevisiae.78 1-Octen-3-ol is a volatile alcohol found in Spirulina platensis (blue-green alga), Pyropia haitanensis (marine red alga), Capsosiphon fulvescens (green alga), and C. vulgaris (green alga).79, 80, 81, 82 It exhibits strong antibacterial activity against S. aureus, B. subtilis, S. epidermidis, E. coli, and Pseudomonas aeruginosa, and it inhibits fungal growth and spore germination in Fusarium tricinctum and Fusarium oxysporum.83 Similarly, hexanal, another VOC found in various algae, demonstrates antimicrobial effects. It is a volatile aldehyde found in C. vulgaris (green alga), Isochrysis galbana (Haptophyceae), and Scenedesmus obliquus (green alga).82,84,85 Hexanal disrupts cell membrane synthesis and mitochondrial function, inducing apoptosis in Aspergillus flavus.86 Furthermore, when A. flavus was exposed to hexanal, it displayed abnormal spore morphology and early spore apoptosis, along with increased production of reactive oxygen species, decreased mitochondrial membrane potential, and DNA fragmentation.86

2.4.1.3. Flavor and aroma

Aroma is a complex blend of numerous volatile compounds, and its composition is specific to each species and often varies by variety.87 Flavor, which is determined by the interplay of taste and odor, can also differ depending on volatile compounds.88 Aroma-active volatiles are significant secondary metabolites, commonly used for their flavor and fragrance in the food, pharmaceutical, and perfume industries to enhance product appeal.89 Because limonene is a principal component of the oil extracted from many citrus plants, it provides their citrus scent and serves as a flavoring agent in foods, beverages, liqueurs, and confections, as well as in aromatic products such as soap, perfumes, and household items.90,91 Hexanal has a fresh, grassy odor and can function as a natural additive that imparts a "fresh green" aroma to plant-based foods, vegetables, and fruits.92 1-Octen-3-ol, also known as mushroom alcohol, is a common aroma component found in most mushrooms that contributes to their flavor and scent.93 In the same way, it is used to enhance the taste of plant-based foods and soups.

2.4.2. Pigments

A pigment is a compound that not only plays an important role in the photosynthetic metabolism and pigmentation of algae but also participates in a number of biological activities. Many microalgae commonly contain pigments such as chlorophyll, carotenoids, and phycobilins.48 First, chlorophyll, a green pigment found in oxygenic photosynthetic organisms such as plants and algae, enables photosynthesis by absorbing and transferring light energy and then converting it into chemical energy. To date, five types of chlorophyll have been identified—chlorophyll a, b, c, d, and f—and all of them share a similar five-membered ring structure; they are classified by their different side chains, which create variations in their light absorption wavelengths.94 Second, carotenoids are fat-soluble compounds that typically appear yellow, orange, or red and are among the most varied and widespread pigments in nature.95 In algae, they serve several crucial functions in photosynthesis. They act as “secondary light-harvesting pigments” that assist the primary pigment, chlorophyll, in capturing light.96 They absorb electromagnetic energy that chlorophyll cannot absorb in the 400 to 500 nm wavelength range and transfer it to chlorophyll.96 Additionally, carotenoids maintain the structure and function of photosynthetic complexes, quench chlorophyll triplet states, neutralize reactive oxygen species, and dissipate excess energy.97 Compared with other pigments, carotenoids have a variety of physiological effects that are particularly advantageous to human health. These effects are generally linked to their antioxidant activity, which prevents the accumulation of free radicals and reactive oxidative species.98 Major carotenoids such as astaxanthin, β-carotene, lutein, lycopene, and canthaxanthin have significant health benefits.99 Third, phycobilins are primarily found in the chloroplast stroma of red algae.96 Phycobilins have the unique characteristic of binding to water-soluble proteins to form phycobiliproteins.96 Like carotenoids, they act as “secondary light-harvesting pigments” that collect light and transfer the energy to chlorophyll.96

2.4.2.1. Antioxidant activities

Carotenoids serve as antioxidants by deactivating electronically activated species, such as singlet oxygen, and reactive chemical species that can cause harmful oxidative reactions, such as peroxyl or alkoxyl radicals.100 Although β-carotene was once regarded as the most notable antioxidant among carotenoids, astaxanthin has recently been revealed to be a more powerful and effective antioxidant agent.101 Naguib, Y.M. used a newly developed fluorometric assay and demonstrated that astaxanthin exhibits the highest antioxidant activity against peroxyl radicals among carotenoids, including lycopene, α-carotene, β-carotene, and lutein.101 The remarkable efficacy of astaxanthin as an antioxidant against lipid peroxidation can be attributed to its unique chemical structure. Carotenoids have a series of conjugated double bonds that allow electrons to delocalize, transfer to radicals, and form resonance structures that stabilize the radicals, preventing oxidative damage.102 Among carotenoids, astaxanthin stands out as the most potent antioxidant due to its 13 double bonds.103 Furthermore, astaxanthin's ability to trap free radicals both within and on the surface of membranes promotes its potency as an antioxidant.104

2.4.2.2. Anti-obesity

Obesity, a chronic condition characterized by excessive body fat, is a growing global concern. It significantly increases the risk of coronary heart disease and its associated risk factors such as hypertension, type 2 diabetes, dyslipidemia, and metabolic syndrome.105 However, obesity is preventable, and pigments from algae offer a promising solution. The green alga Caulerpa racemosa contains seven carotenoids, with β-carotene and canthaxanthin being the most prevalent.106 The carotenoid extract from C. racemosa has demonstrated potent biological activity, inhibiting enzymes such as α-glucosidase, α-amylase, and lipase and upregulating AMPK, which makes it a potential candidate for anti-obesity drugs.106 Additionally, the extract exhibits low cytotoxicity in normal cells, enhancing its potential for development into nutraceuticals and pharmaceuticals.106

In Spirulina platensis, a blue-green alga, both chlorophyll a and a type of phycobilin, C-phycocyanin, have been found to reduce lipid droplet accumulation.107,108 In 3T3-L1 and C3H10T1/2 cells, they decreased the expression of adipogenic (C/EBPα, PPARγ, and aP2) and lipogenic proteins (LPAATβ, lipin1, and DGAT1).107

Fucoxanthin, a major carotenoid found in edible seaweeds such as Undaria pinnatifida and Hizikia fusiformis, along with its metabolite fucoxanthinol, inhibits the differentiation of 3T3-L1 preadipocytes into adipocytes by downregulating PPARγ.109, 110, 111 In rats and mice, being fed lipids derived from U. pinnatifida led to a reduction in the weight of abdominal white adipose tissue (WAT).112 These lipids, called Undaria lipids, were primarily composed of glycolipids and the carotenoid fucoxanthin.112 Notably, in mice that were fed fucoxanthin, WAT weight decreased significantly, and that was accompanied by a marked increase in the expression of UCP1 in the WAT.112 In contrast, mice fed only glycolipids showed no change in WAT weight and minimal UCP1 expression.112 This result suggests that fucoxanthin promotes UCP1 expression in WAT, contributing to fat reduction.112 UCP1, which plays a key role in energy expenditure in brown adipose tissue, is essential for maintaining whole-body energy balance, at least in small rodents, and dysfunction in UCP1 expression is linked to obesity.113 These findings highlight the potential of algal pigments to address obesity through multiple biological pathways.

2.4.3. Phenolic compounds

Phenolic compounds are characterized by the presence of one or more hydroxyl groups attached to an aromatic ring.114 These compounds, which range from simple molecules such as phenolic acids and flavonoids to more complex forms such as tannins and lignins, represent a broad and diverse group of natural substances.115 Among them, flavonoids are the most common and widely distributed subgroup.115 Their beneficial physiological effects include anti-inflammatory, antimicrobial, antioxidant, and cardioprotective properties, as well as anti-thrombotic and vasodilatory actions.116,117 The antioxidant capacity of phenolic compounds is particularly important, as it underpins many of these health benefits.118

3. Chemical composition of Chlorella vulgaris

3.1. Proteins

Protein composes 40 % to 58 % of the dry weight of C. vulgaris biomass.119, 120, 121, 122 According to the recommended daily intake of essential amino acids published by the WHO (World Health Organization) and FAO (Food and Agriculture Organization) (Table 1), C. vulgaris provides an adequate supply of essential amino acids.7

Table 1.

Amino acid profile of C. vulgaris compared with the recommended daily intake of essential amino acids from FAO/WHO (Table modified from7).

Amino acids C. vulgaris C. vulgaris120 C. vulgaris123 Recommendations from FAO/WHO
Essential amino acids
Threonine 5.30 6.09 5.15 4.00
Valine 7.00 3.09 6.61 5.00
Methionine 1.30 0.65 1.24 N/A1
Isoleucine 3.20 0.09 4.44 4.00
Leucine 9.50 7.49 9.38 7.00
Phenylalanine 5.50 5.81 5.51 N/A
Histidine 2.00 1.25 1.97 N/A
Lysine 6.40 6.83 6.68 5.50
Tryptophan n.d.2 2.21 2.30 1.00
Non-essential amino acids
Aspartic acid 9.30 10.94 9.80 N/A
Serine 5.80 7.77 4.32 N/A
Glutamic acid 13.70 9.08 12.66 N/A
Glycine 6.30 8.60 6.07 N/A
Alanine 9.40 10.90 8.33 N/A
Cysteine n.d. 0.19 1.28 3.50
Tyrosine 2.80 8.44 3014 6.00
Arginine 6.90 7.38 6.22 N/A
Ornithine n.d. 2.21 2.30 N/A
Proline 5.00 2.97 4.90 N/A

N/A: not available; n.d.: not detected.

3.2. Carbohydrates

The dry matter of C. vulgaris contains 12–17 % carbohydrates.124 The cell wall features a carbohydrate matrix of polysaccharides, such as cellulose and β−1,3-glucan, and monosaccharides such as rhamnose, galactose, and xylose, which provide both rigidity and elasticity.125, 126, 127, 128 In particular, β−1,3-glucan acts as an immune stimulator, a free-radical scavenger, and a reducer of blood lipids.129 Inside, on the other hand, the cell wall contains polysaccharides such as starch and monosaccharides such as glucose, galactose, and arabinose that can be used in metabolism.130

3.3. Lipids

Under optimal growth conditions, the lipid content of C. vulgaris is between 5 % and 40 %, but it can increase to 58 % in unfavorable conditions.131 The lipids mainly consist of triglycerides, which include mono- to polyunsaturated fatty acids, as well as polar fatty acids such as phospholipids and glycolipids (Table 2). Moreover, it contains approximately 0.9 % sterols, including 0.6 % beta-sitosterol, 0.15 % campesterol, and 0.1 % stigmasterol, which, although present in small amounts, are sufficient for their biological functions.132 Among the various types of lipids, fatty acids—the biologically active components—are key constituents of the lipid profile of C. vulgaris. Their composition is presented below.133

Table 2.

Fatty acid composition of C. vulgaris (percent of fatty acids).133

Fatty acid Name %
∑ Saturated 25.38
∑ Short chain (4:0–18:0) 25.02
4:0 Butyric 0.20
6:0 Caproic 2.77
8:0 Caprylic 0.26
11:0 Undecylenic 1.39
12:0 Lauric 0.87
13:0 Tridecanoic 1.03
14:0 Myristic 0.69
15:0 Pentadecanoic 1.70
16:0 Palmitic 14.42
17:0 Margaric 0.12
18:0 Stearic 1.57
∑ Long chain (20:0–24:0) 0.36
20:0 Arachidic 0.14
23:0 Tricosanoic Nd 1
24:0 Tetracosanoic 0.22
∑ Unsaturated 66.34
∑ Monodiens 28.04
11:1 Undecylenic 2.17
12:1 Lauroleic 0.41
15:1 Pentadecenoic 3.53
16:1 Palmitoleic 4.04
17:1 Heptadecenoic 0.27
18:1 Oleic 17.62
22:1 Docosaenoic Nd
24:1 Tetracosenoic Nd
∑Dienes 17.31
16:2 Hexadecadienoic 5.34
18:2 (ω−6) Linoleic 11.97
20:2 (ω−6) Eicosadienoic Nd
∑Trienes 20.69
16:3 Hexadecatrienoic 4.90
18:3 (ω−6) Gamma linolenic Nd
18:3 (ω−3) Alpha linolenic 15.79
20:3 (ω−8) Dihomolinolenic Nd
20:5 (ω−3) Eicosapentaenoic (EPA) Nd
22:6 (ω−3) Docosahexaenoic (DHA) 0.30
∑Others 8.28
1

Nd, Not detected.

3.4. Secondary metabolites

3.4.1. Volatile compounds

Even though volatile compounds (VOCs) are present in much lower quantities than other chemical components, they exhibit significant biological activity. The VOCs consist of hydrocarbons, acids, alcohols, esters, aldehydes, and ketones, accounting for 33.67 %, 23.93 %, 15.62 %, 8.02 %, 3.24 %, and 2.71 % of the total VOCs (Table 3), respectively.134 Concrete volatile compounds, identified by chromatography and GC/MS, are shown in the table below.

Table 3.

Composition (%) of C. vulgaris volatile compounds.134

Class Compounds %
Hydrocarbon α-pinene 2.11
β-pinene 7.63
Dodecane 1.76
Hexadecene 15.30
Heptadecane 0.74
Heptadecene 2.11
Octadecane 3.21
Tetracosane 0.35
Heptacosane 0.55
Acid Dodecanoic 0.2
Tetradecanoic 0.9
Hexadecanoic 8.73
Octadecanoic 2.2
Octadec-9-enoic 0.73
Octa-9,12-dienoic 10.20
Octadec-9,12,15-trienoic 0.97
Alcohol Hexadecanol 10.80
Octadecanol 2.30
Nonadecanol 2.01
Phytol 0.51
Ester Methyl-hexadecanoate 2.20
Methyl-octadecanoate 3.52
Methyl-octadec-9-enoate 0.98
Methyl-octadec-9,12-dienoate 1.32
Aldehyde Hexanal 0.14
Nonadecanal 0.90
Hexadecanal 2.20
Ketone Decanone 0.7
Hexadecanone 1.70
β-ionone 0.13
α-ionone 0.18
Unidentified 12.72

Total 100

3.4.2. Pigments

Similarly, pigments constitute only a small portion of C. vulgaris. The majority consists of carotenoids, chlorophyll, or chlorophyll derivatives (Table 4).7

Table 4.

Potential pigment content of C. vulgaris under different growth conditions.7

Pigments μgg−1 (dw)
β-Carotene 7–12,000
Astaxanthin 550,000
Canthaxanthin 362,000
Lutein 52–3830
Chlorophyll-α 250–9630
Chlorophyll-β 72–5770
Pheophytin-α 2310–5640
Violaxanthin 10–37

3.4.3. Phenolic compounds

C. vulgaris harbors polyphenols and can produce them directly. In dietary supplements containing C. vulgaris, polyphenols such as p-hydroxybenzoic acid, p-coumaric acid, cinnamic acid, kaempferol 7-rhamnoside, epigallocatechin, epigallocatechin gallate, and apigenin have been identified.135 Furthermore, it has been confirmed that phenolic compounds, including gallic acid, caffeic acid, p-coumaric acid, and ferulic acid, can be extracted from C. vulgaris using polyol-based deep eutectic solvents.136

3.4.4. Other secondary metabolites

The petroleum ether extract of Chlorella demonstrated a significant presence of alkaloids, a moderate amount of terpenoids and flavonoids, and a low level of tannins and polyphenols (Table 5).137 Similarly, the methanolic extract exhibited a high content of polyphenols and saponins, along with a measurable quantity of tannins, cardiac glycosides, and quinones (Table 5).137

Table 5.

Levels of secondary phytochemicals in petroleum ether and methanolic extracts of C. vulgaris.137

Secondary Phytochemicals C. Vulgaris
Petroleum ether Methanol
Alkaloids +++ 1 ND
Terpenoids ++ 2 ND
Flavonoids ++ ND
Tannins + 3 ++
Polyphenols + +++
Saponins ND +++
Cardiac glycosides ND ++
Quinones ND ++
1

+++, abundant presence.

2

++, moderate presence.

3

+, poor presence.

4. Biological activities of Chlorella vulgaris

Variety of biological activities of Chlorellar vulgaris including antioxidative, antimicrobial, anti-cancer, anti-obesity, anti-inflammatory, immune-stimulatory, are summarized in Fig. 1.

Fig. 1.

Fig. 1

Biological Activities ofChlorella Vulgaris.

4.1. Antioxidant activity

A methanolic extract of C. vulgaris demonstrated significant antioxidant activity, effectively scavenging various free radicals, as indicated by low IC50 values: 2.82 ± 0.30 μg/ml for DPPH radicals, 2.30 ± 0.25 μg/ml for hydroxyl radicals, 3.24 ± 0.32 μg/ml for hydrogen peroxide (H₂O₂), and 3.15 ± 0.02 μg/ml for superoxide radicals.138 Additionally, extracts obtained using supercritical carbon dioxide (SC—CO₂) technology exhibited strong antioxidant properties, showcasing effective radical scavenging, ferric reducing power, and metal chelation capabilities.139 Furthermore, the compound (2E,7R,11R)-3,7,11,15-tetramethyl-2-hexadecenol isolated from C. vulgaris revealed high antioxidant potential, with an IC50 of 10.59 μg/ml in the DPPH radical assay.140 This level of activity is comparable to that of well-known antioxidants such as butylated hydroxy toluene, which has an IC50 of 11.2 μg/ml, and vitamin C, which has an IC50 of 12.9 μg/ml.140

4.2. Antimicrobial activity

The methanolic extract of C. vulgaris demonstrated potent antibacterial activity, evidenced by a decrease in colony-forming units (cfu × 107/ml) and cell viability percentage.138 The chloroform extract of C. vulgaris exhibited substantial antimicrobial effects against two Gram-positive bacteria (Bacillus subtilis and Staphylococcus aureus), two Gram-negative bacteria (E. coli and Pseudomonas aeruginosa), and the fungal strain Candida albicans, as shown by the agar well diffusion assay.141 Additionally, the ethanol extract was found to be effective against Klebsiella sp.142 Moreover, the ethanolic extract of C. vulgaris (ECV) has been investigated for its antiviral properties against the Newcastle disease virus (NDV), with promising results obtained in both in vitro and in vivo studies.143 In vitro, a 100 µL dose of ECV led to a significant reduction in viral titer from 108.5 EID50/ml to 103.4 EID50/ml, achieving complete inhibition of NDV replication and preventing hemagglutination, all while showing no toxicity to embryonated chicken eggs.143 In the subsequent in vivo study, 28-day-old Sasso chickens were given a nontoxic dose of 1 g/kg of ECV in their drinking water both before and after exposure to NDV.143 Evaluations of clinical signs, post-mortem lesions, and histopathological assessments revealed that the extract effectively hindered viral replication in the treated groups, compared with the controls.143 Additionally, a real-time PCR analysis showed a marked decrease in viral shedding on days 3 and 5 post-challenge, with no detectable viral titer by day 7 in the prophylactic group.143 These findings highlight the potential of C. vulgaris extract as an effective antiviral agent against NDV in real-world conditions.143

4.3. Anti-cancer activity

The extract of C. vulgaris from SC—CO2 technology demonstrated an ability to inhibit the proliferation of H1299, A549, and H1437 human lung cancer cells in a dose-dependent manner.139 In addition, treatment with C. vulgaris significantly reduced tumor cell migration, indicating the extract's potential role to prevent lung cancer metastasis.139 Furthermore, methanol extracts of C. vulgaris exhibited significant cytotoxic effects against the MCF-7 breast cancer cell line.144 The pure compound (2E,7R,11R)-3,7,11,15-tetramethyl-2-hexadecenol, isolated from C. vulgaris extract, displayed strong anticancer activity against the HeLa cell line, achieving an IC50 value of 4.38 μg/ml, which is notably lower than that of the synthetic drug doxorubicin, which has an IC50 of 13.3 μg/ml.140

4.4. Anti-inflammatory activity

The 80 % methanolic extract demonstrated the most potent anti-inflammatory effects by significantly inhibiting the production of nitric oxide, prostaglandin E, TNF-α, and IL-6 in LPS-induced RAW 264.7 cells (P < 0.001).145 Furthermore, both the hexane and chloroform fractions displayed notable and dose-dependent suppression of inflammatory mediators and cytokines induced by LPS in vitro.145

4.5. Anti-obesity

A heterotrophic extraction of C. vulgaris using ethanol and ultrasound treatment resulted in a considerable reduction of Nile red fluorescence, which indicates the depletion of neutral lipid reserves.146 This effect was comparable to that achieved by the positive control, resveratrol.146

4.6. Immune function

The nutritional parameters and levels of IFN-γ in the blood serum of a group of mice treated with C. vulgaris (0.15 g/kg) showed marked improvements compared with the untreated group on a protein-energy malnutrition diet, which is associated with a weakened immune defense.147 Furthermore, treatment with C. vulgaris at a concentration of 1 mg/mL led to a notable increase in the production of both IFN-γ and IL-2, compared with the control group.147 These results indicate that C. vulgaris could play a beneficial role in enhancing immune function.147

4.7. Pharmacological applications

The antioxidant, antimicrobial, and immunomodulatory properties of C. vulgaris underscore its pharmacological significance, in addition to its role in wound healing. A hydrogel formulation containing C. vulgaris cultivated in mixotrophic conditions has been shown to enhance wound healing in mice.148 This formulation led to increased collagen deposition, skin appendages, and a reduction of inflammatory cells, as well as clear signs of basal laminae, compared with the control groups.148 These pro-healing and anti-inflammatory characteristics, coupled with its antioxidant and antibacterial activities, suggest that C. vulgaris could serve as a promising topical treatment for various skin ailments, including both acute and chronic wounds.148

Moreover, an ointment derived from C. vulgaris containing 15 % extract demonstrated considerable effectiveness in speeding the wound healing process in pig ears, as evidenced by improvements in healing parameters and an increase in the number of fibroblast cells, compared with control groups that did not receive the extract.149 Fibroblasts play a crucial role in producing collagen and extracellular matrix components, which are essential for replacing blood clots with granulation tissue—a temporary matrix in the healing process that ultimately transforms into scar tissue.150 The presence of collagen is vital for repairing damage and restoring both anatomical structure and tissue function.150,151 C. vulgaris contains a variety of beneficial phytochemical compounds such as chlorophyll, carotenoids, phycobilin, Chlorella growth factor, sterols, flavonoids, tannins, phenols, terpenoids, saponins, sulfur compounds, and other nutrients, all of which further facilitate the healing process.149

4.8. Cardiovascular health

Chlorella microalgae are regarded as promising species for tissue regeneration, particularly in repairing joint injuries and protecting the cardiovascular system. C. vulgaris has been found to reduce arterial collagen degradation, which can help prevent diseases such as atherosclerosis.152 Furthermore, the daily intake of Chlorella supplements has demonstrated potential health benefits in individuals with mild hypercholesterolemia by lowering serum lipid levels, particularly triglycerides and total cholesterol, which are considered major risk factors for cardiovascular diseases.153 Peptidic fractions from peptic digests of C. vulgaris were isolated through ion exchange chromatography and gel filtration.154 The fractions showed the ability to inhibit angiotensin I-converting enzyme (ACE).154 When administered orally to spontaneously hypertensive rats (SHRs) at a dose of 200 mg/kg, these peptides were found to reduce hypertension, another critical risk factor for cardiovascular diseases.154

In addition, a novel ACE inhibitory peptide, Val-His-Trp (VHW), was identified from a peptide library derived from C. vulgaris proteins.155 When administered to SHRs at a dose of 5 mg/kg, the VHW peptide caused a 50 mmHg reduction in systolic blood pressure (SBP), with a maximum drop from 234 to 184 mmHg within 2 h.155 Remarkably, VHW reduced SBP by 31 mmHg by the end of the observation period, whereas the control drug, lisinopril, caused only a 10 mmHg reduction.155 This suggests that C. vulgaris–derived peptides could be effective at lowering blood pressure, even at relatively low doses.155

5. Active compounds in Chlorella vulgaris

The petroleum etheric extract of Chlorella revealed the presence of three bioactive compounds, dodecanoic acid, 6, 7-dimethoxy-2-tetralone and 3, 7, 11, 15-tetramethyl-2-hexadecen-1-ol, whereas the methanolic extract showed five bioactive compounds, phenol, 2‑methoxy‑5-(1-propenyl)-,(E), cycloheptane, 1, 3, 5-tris (methylene), 4-(6, 6-dimethyl-2-methylenecyclohex-3-enylidene) pentan-2-ol, tetradecanoic acid, and loliolide (Fig. 2).137

Fig. 2.

Fig. 2

Seven bioactive compounds extracted fromC. vulgaris.156, 157, 158, 159, 160, 161, 162

5.1. Dodecanoic acid (C12H24O2)

Dodecanoic acid, also called dodecylic acid, N-dodecanoic acid, and lauric acid, is a saturated fatty acid known for its wide range of biological activities.137 It has been reported to exhibit antibacterial, antifungal, antitumor, anti-inflammatory, antimycobacterial, and antiviral properties, making it a compound of significant interest in therapeutic and pharmaceutical applications.163, 164, 165, 166, 167, 168

5.2. 6, 7-Dimethoxy-2-tetralone (C12H14O3)

This compound, a phenolic derivative, is also called 6,7-dimethoxy-3,4-dihydronaphthalen-2(1H)-one, 6,7-dimethoxy-3,4-dihydro-1H-naphthalen-2-one, and 6,7-dimethoxyl-2-tetralone.137 It serves as a key precursor in the production of numerous dopaminergic compounds.137 Additionally, it plays a crucial role in chemical synthesis, such as forming 2-bromotetralones through bromination.137 This compound has also been used to create quinolines with dopaminergic effects, naphthols with anti-inflammatory properties, and benzophenanthridine alkaloids known for their antitumor activities.137,169

5.3. 3, 7, 11, 15-Tetramethyl-2-hexadecen-1-ol (C20H40O)

This compound, a diterpenoid and a long-chain primary fatty alcohol, is also called phytol, 3,7,11,15-tetramethylhexadec-2-en-1-ol, and 2-hexadecen-1-ol, 3,7,11,15-tetramethyl.137 It exhibits a wide array of biological properties, including anxiolytic, cytotoxic, antioxidant, and apoptosis-inducing effects. Additionally, it has been shown to modulate metabolism and demonstrate anti-nociceptive, anti-inflammatory, anticancer, diuretic, and antimicrobial activity. Phytol also exhibits insecticidal, anti-tuberculosis, immune-modulating, and protective properties against oxidative stress.170, 171, 172 These diverse effects highlight its potential in various therapeutic and industrial applications.

5.4. Phenol, 2‑methoxy‑5-(1-propenyl)-(E) (C10H12O2)

This phenolic compound, also called isoeugenol, isochavibetol, 2‑methoxy‑5-[(E)-1-propenyl] phenol, and 2‑methoxy‑5-[(E)‑prop‑1-enyl] phenol, is notable for its diverse applications.137 Isoeugenol, particularly in its acetate ester form, is a precursor in vanillin production.137 It is also a non-cannabinoid phenol present in cannabis plants.137,173 Widely used as both a food flavoring and fragrance agent, it contributes to the characteristic taste of nutmeg and serves as a scent component in soaps, shampoos, perfumes, detergents, and bath tissues. Despite its widespread use, isoeugenol is recognized as a potent contact allergen.137,174

5.5. 4-(6, 6-Dimethyl-2-methylenecyclohex-3-enylidene) pentan-2-ol (C14H22O)

This terpenoid, also called (4Z)-4-(6,6-dimethyl-2-methylene-3-cyclohexen-1-ylidene)-2-pentanol, serves multiple industrial purposes. It is commonly used as a solvent and an intermediate in the synthesis of various chemicals.137 At room temperature, it appears as a colorless liquid with a characteristic fuel-like odor.137 Its applications extend to the production of pharmaceuticals, herbicides, antioxidants, extractants, and cosmetics, highlighting its versatility in manufacturing and industrial processes.137

5.6. Tetradecanoic acid (C14H28O2)

This saturated fatty acid is also called myristic acid, n-tetradecanoic acid, and crodacid.137 Tetradecanoic acid used as an antioxidant, lubricant, hypercholesterolemic, cancer-preventive, and cosmetic.137,175, 176, 177

5.7. Loliolide (C11H16O3)

Loliolide, also called (3S,5R)-loliolide, is a terpenoid with diverse biological activities. It has demonstrated the ability to inhibit cellular senescence in human dermal fibroblasts by reducing senescence-associated β-galactosidase activity, p21 protein levels, and reactive oxygen species in cells subjected to adriamycin treatment.137 Functioning as a selective estrogen receptor modulator, it activates ERβ and ERα receptors while exhibiting estrogenic effects.137 These properties make loliolide valuable for medicinal and dietary applications aimed at alleviating estrogen deficiency–related conditions, particularly post-menopause.137 Moreover, loliolide has shown potential as a hepatitis C virus entry inhibitor, suggesting its role as a candidate antiviral agent.137,178 Additionally, it is recognized as a promising anti-adipogenic compound for potential use in anti-obesity therapies. Beyond those applications, it exhibits antibacterial, anti-inflammatory, antidepressant, and anticancer effects, showcasing its versatility in pharmaceutical and therapeutic contexts.179

6. Conclusions and perspectives

This article addresses biological activities of Chlorella vulgaris, the most abundantly and extensively obtained and consumed in East Asian countries. Chlorella vulgaris is a versatile microalga with multifunctional properties ranging from therapeutic biological activities – such as antioxidant, antimicrobial activity, and anti-cancer activity – to attributes with potential for industrial applications including bioplastic and cosmetics. Furthermore, 7 major active compounds of Chlorella vulgaris are elucidated with emphasis on their health-promoting characteristics. In spite of great progress in Chlorella vulgaris research, several challenges still remain. Most of the studies are confined to in vitro experiments, thus, it may be premature to implement in human trials. Moreover, Chlorella vulgaris extracts are collected in different ways by each experiment. Therefore, extraction methods need to be standardized for reproducibility and efficacy. As a final addition, the underlying mechanisms of action of active compounds should be investigated. Therefore, future research should aim to delve into the molecular mechanisms behind these bioactivities and further sequential studies should be conducted, progressing from in vivo to clinical investigations. These studies will help determine how the promising effects observed in preclinical models manifest in humans, providing concrete insights into potential health benefits. By establishing whether these pharmacological effects translate into tangible improvements in human well-being, such clinical investigations will clarify the real-world applicability of Chlorella vulgaris, guide evidence-based usage, and lay the foundation for future interventions aimed at promoting human health.

Funding

This research was supported by the Basic Science Research Program (2017R1A6A1A03015642) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education.

Ethics statement

Not applicable.

Data availability

Data sharing is not applicable to this review article.

CRediT authorship contribution statement

Yein Heo: Conceptualization, Methodology, Formal analysis, Investigation, Data curation, Writing – original draft. Mi-Yeon Kim: Software, Validation, Formal analysis, Writing – review & editing, Visualization. Jae Youl Cho: Conceptualization, Supervision, Project administration, Funding acquisition.

Declaration of competing interest

The authors declare that they have no conflicts of interest.

Contributor Information

Mi-Yeon Kim, Email: kimmy@ssu.ac.kr.

Jae Youl Cho, Email: jaecho@skku.edu.

References

  • 1.Ullmann J., Grimm D. Algae and their potential for a future bioeconomy, landless food production, and the socio-economic impact of an algae industry. Organic Agric. 2021;11(2):261–267. [Google Scholar]
  • 2.El Gamal A.A. Biological importance of marine algae. Saudi pharmaceutical journal. 2010;18(1):1–25. doi: 10.1016/j.jsps.2009.12.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Hillson C.J. Penn State Press; 1977. Seaweeds: a Color-Coded, Illustrated Guide to Common Marine Plants of the East Coast of the United States. [Google Scholar]
  • 4.Pereira L. Macroalgae. Encyclopedia (Basel, 2021) 2021;1(1):177–188. [Google Scholar]
  • 5.Chapman R.L. Algae: the world’s most important “plants”—An introduction. Mitig Adapt Strateg Glob Chang. 2013;18:5–12. [Google Scholar]
  • 6.Ditfurth Hv. Hoffmann u. Campe; 1979. Im Anfang war Der Wasserstoff. [Google Scholar]
  • 7.Safi C., Zebib B., Merah O., Pontalier P.-Y., Vaca-Garcia C. Morphology, composition, production, processing and applications of chlorella vulgaris: a review. Renew Sustain Energy Rev. 2014;35:265–278. [Google Scholar]
  • 8.Liu J., Chen F. Biology and industrial applications of Chlorella: advances and prospects. Microal Biotechnol. 2016:1–35. doi: 10.1007/10_2014_286. [DOI] [PubMed] [Google Scholar]
  • 9.Alberts B. Molecular biology of the cell. 4th edition. 2002. [Google Scholar]
  • 10.Palmer R.M., Ashton D., Moncada S. Vascular endothelial cells synthesize nitric oxide from l-arginine. Nature. 1988;333(6174):664–666. doi: 10.1038/333664a0. [DOI] [PubMed] [Google Scholar]
  • 11.Brunet L.R. Nitric oxide in parasitic infections. Int Immunopharmacol. 2001;1(8):1457–1467. doi: 10.1016/s1567-5769(01)00090-x. [DOI] [PubMed] [Google Scholar]
  • 12.Kröncke K.-D., Fehsel K., Suschek C., Kolb-Bachofen V. Inducible nitric oxide synthase-derived nitric oxide in gene regulation, cell death and cell survival. Int Immunopharmacol. 2001;1(8):1407–1420. doi: 10.1016/s1567-5769(01)00087-x. [DOI] [PubMed] [Google Scholar]
  • 13.Ochoa J.B., Strange J., Kearney P., Gellin G., Endean E., Fitzpatrick E. Effects of l-arginine on the proliferation of T lymphocyte subpopulations. J Parent Enteral Nutrition. 2001;25(1):23–29. doi: 10.1177/014860710102500123. [DOI] [PubMed] [Google Scholar]
  • 14.Trimarco V., Izzo R., Lombardi A., Coppola A., Fiorentino G., Santulli G. Beneficial effects of l-Arginine in patients hospitalized for COVID-19: new insights from a randomized clinical trial. Pharmacol Res. 2023;191 doi: 10.1016/j.phrs.2023.106702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Zhang Y.-J., Gan R.-Y., Li S., et al. Antioxidant phytochemicals for the prevention and treatment of chronic diseases. Molecules. 2015;20(12):21138–21156. doi: 10.3390/molecules201219753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Shin E.-S., Hwang H.-J., Kim I.-H., Nam T.-J. A glycoprotein from Porphyra yezoensis produces anti-inflammatory effects in liposaccharide-stimulated macrophages via the TLR4 signaling pathway. Int J Mol Med. 2011;28(5):809–815. doi: 10.3892/ijmm.2011.729. [DOI] [PubMed] [Google Scholar]
  • 17.Silva L.M.C.M., Lima V., Holanda M.L., et al. Antinociceptive and anti-inflammatory activities of lectin from marine red alga Pterocladiella capillacea. Biol Pharmaceut Bulletin. 2010;33(5):830–835. doi: 10.1248/bpb.33.830. [DOI] [PubMed] [Google Scholar]
  • 18.Shih C.-M., Cheng S.-N., Wong C.-S., Kuo Y.-L., Chou T.-C. Antiinflammatory and antihyperalgesic activity of C-phycocyanin. Anesth Anal. 2009;108(4):1303–1310. doi: 10.1213/ane.0b013e318193e919. [DOI] [PubMed] [Google Scholar]
  • 19.Romay C., Armesto J., Remirez D., González R., Ledon N., Garcia I. Antioxidant and anti-inflammatory properties of C-phycocyanin from blue-green algae. Inflamm Res. 1998;47:36–41. doi: 10.1007/s000110050256. [DOI] [PubMed] [Google Scholar]
  • 20.Moaveni S., Salami M., Khodadadi M., McDougall M., Emam-Djomeh Z. Investigation of S. limacinum microalgae digestibility and production of antioxidant bioactive peptides. Lwt. 2022;154 [Google Scholar]
  • 21.Bertin R., Chen Z., Marin R., et al. Activity of myricetin and other plant-derived polyhydroxyl compounds in human LDL and human vascular endothelial cells against oxidative stress. Biomed Pharmacoth. 2016;82:472–478. doi: 10.1016/j.biopha.2016.05.019. [DOI] [PubMed] [Google Scholar]
  • 22.Alzahrani M.A.J., Perera C.O., Hemar Y. Production of bioactive proteins and peptides from the diatom nitzschia laevis and comparison of their in vitro antioxidant activities with those from Spirulina platensis and Chlorella vulgaris. Int J Food Sci Technol. 2018;53(3):676–682. [Google Scholar]
  • 23.Khavari F., Saidijam M., Taheri M., Nouri F. Microalgae: therapeutic potentials and applications. Mol Biol Rep. 2021;48(5):4757–4765. doi: 10.1007/s11033-021-06422-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Picciotto S., Barone M.E., Fierli D., et al. Isolation of extracellular vesicles from microalgae: towards the production of sustainable and natural nanocarriers of bioactive compounds. Biomater Sci. 2021;9(8):2917–2930. doi: 10.1039/d0bm01696a. [DOI] [PubMed] [Google Scholar]
  • 25.M-j Chanda, N Merghoub, El Arroussi H. Microalgae polysaccharides: the new sustainable bioactive products for the development of plant bio-stimulants? World J Microb Biotechnol. 2019;35(11):177. doi: 10.1007/s11274-019-2745-3. [DOI] [PubMed] [Google Scholar]
  • 26.Costa J.A.V., Lucas B.F., Alvarenga A.G.P., Moreira J.B., de Morais M.G. Microalgae polysaccharides: an overview of production, characterization, and potential applications. Polysaccharides. 2021;2(4):759–772. [Google Scholar]
  • 27.Gaignard C., Gargouch N., Dubessay P., et al. New horizons in culture and valorization of red microalgae. Biotechnol Adv. 2019;37(1):193–222. doi: 10.1016/j.biotechadv.2018.11.014. [DOI] [PubMed] [Google Scholar]
  • 28.Chen C.-Y., Zhao X.-Q., Yen H.-W., et al. Microalgae-based carbohydrates for biofuel production. Biochem Eng J. 2013;78:1–10. [Google Scholar]
  • 29.Mišurcováa L., Orsavováb J., Ambrožováa J.V. Algal polysaccharides and health. Polysaccharides: Bioact Biotechnol; Springer Int Publish: Cham, Switzerland. 2014:110–144. [Google Scholar]
  • 30.Muthukumar J., Chidambaram R., Sukumaran S. Sulfated polysaccharides and its commercial applications in food industries—A review. J Food Sci Technol. 2021;58:2453–2466. doi: 10.1007/s13197-020-04837-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Arad S.M., Levy-Ontman O. Red microalgal cell-wall polysaccharides: biotechnological aspects. Curr Opin Biotechnol. 2010;21(3):358–364. doi: 10.1016/j.copbio.2010.02.008. [DOI] [PubMed] [Google Scholar]
  • 32.Chaisuwan W., Phimolsiripol Y., Chaiyaso T., et al. The antiviral activity of bacterial, fungal, and algal polysaccharides as bioactive ingredients: potential uses for enhancing immune systems and preventing viruses. Front Nutr. 2021;8 doi: 10.3389/fnut.2021.772033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Andrew M., Jayaraman G. Marine sulfated polysaccharides as potential antiviral drug candidates to treat Corona Virus disease (COVID-19) Carbohydr Res. 2021;505 doi: 10.1016/j.carres.2021.108326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Witvrouw M., De Clercq E. Sulfated polysaccharides extracted from sea algae as potential antiviral drugs. General Pharmacol: Vascular System. 1997;29(4):497–511. doi: 10.1016/s0306-3623(96)00563-0. [DOI] [PubMed] [Google Scholar]
  • 35.Damonte E.B., Matulewicz M.C., Cerezo A.S. Sulfated seaweed polysaccharides as antiviral agents. Curr Med Chem. 2004;11(18):2399–2419. doi: 10.2174/0929867043364504. [DOI] [PubMed] [Google Scholar]
  • 36.Huheihel M., Ishanu V., Tal J., Arad S.M. Activity of porphyridium sp. polysaccharide against herpes simplex viruses in vitro and in vivo. J Biochem Biophys Methods. 2002;50(2–3):189–200. doi: 10.1016/s0165-022x(01)00186-5. [DOI] [PubMed] [Google Scholar]
  • 37.de Jesus, Raposo M.F., de Morais A.M.M.B., de Morais R.M.S.C. Influence of sulphate on the composition and antibacterial and antiviral properties of the exopolysaccharide from porphyridium cruentum. Life Sci. 2014;101(1–2):56–63. doi: 10.1016/j.lfs.2014.02.013. [DOI] [PubMed] [Google Scholar]
  • 38.Huang J., Chen B., You W. Studies on separation of extracellular polysaccharide from porphyridium cruentum and its anti-HBV activity in vitro. Chin J Marine Drugs. 2001 [Google Scholar]
  • 39.Hayashi T., Hayashi K., Maeda M., Kojima I. Calcium spirulan, an inhibitor of enveloped virus replication, from a blue-green alga Spirulina platensis. J Nat Prod. 1996;59(1):83–87. doi: 10.1021/np960017o. [DOI] [PubMed] [Google Scholar]
  • 40.Hayashi K., Hayashi T., Kojima I. A natural sulfated polysaccharide, calcium spirulan, isolated from Spirulina platensis: in vitro and ex vivo evaluation of anti-herpes simplex virus and anti-human immunodeficiency virus activities. AIDS Res Hum Retroviruses. 1996;12(15):1463–1471. doi: 10.1089/aid.1996.12.1463. [DOI] [PubMed] [Google Scholar]
  • 41.Rocha de Souza M.C., Marques C.T., Guerra Dore C.M., Ferreira da Silva F.R., Oliveira Rocha H.A., Leite E.L. Antioxidant activities of sulfated polysaccharides from brown and red seaweeds. J Appl Phycol. 2007;19:153–160. doi: 10.1007/s10811-006-9121-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Wang J., Zhang Q., Zhang Z., Song H., Li P. Potential antioxidant and anticoagulant capacity of low molecular weight fucoidan fractions extracted from Laminaria japonica. Int J Biol Macromol. 2010;46(1):6–12. doi: 10.1016/j.ijbiomac.2009.10.015. [DOI] [PubMed] [Google Scholar]
  • 43.Mohan S.C., Thirupathi A. Springer; 2021. Polysaccharides of Microbial Origin: Biomedical Applications; pp. 1–27. [Google Scholar]
  • 44.Mousavian Z., Safavi M., Azizmohseni F., Hadizadeh M., Mirdamadi S. Characterization, antioxidant and anticoagulant properties of exopolysaccharide from marine microalgae. AMB Express. 2022;12(1):27. doi: 10.1186/s13568-022-01365-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Trabelsi L., Chaieb O., Mnari A., Abid-Essafi S., Aleya L. Partial characterization and antioxidant and antiproliferative activities of the aqueous extracellular polysaccharides from the thermophilic microalgae Graesiella sp. BMC Complement Altern Med. 2016;16:1–10. doi: 10.1186/s12906-016-1198-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Mishima T., Murata J., Toyoshima M., et al. Inhibition of tumor invasion and metastasis by calciumspirulan (Ca-SP), a novel sulfated polysaccharide derived from a blue-green alga, Spirulina platensis. Clin Exp Metastasis. 1998;16:541–550. doi: 10.1023/a:1006594318633. [DOI] [PubMed] [Google Scholar]
  • 47.Gardeva E., Toshkova R., Minkova K., Gigova L. Cancer protective action of polysaccharide, derived from red microalga porphyridium cruentum—A biological background. Biotechnol Biotechnol Equipm. 2009;23(sup1):783–787. [Google Scholar]
  • 48.D’Alessandro E.B. Antoniosi Filho NR. Concepts and studies on lipid and pigments of microalgae: a review. Renew Sustain Energy Rev. 2016;58:832–841. [Google Scholar]
  • 49.Shimizu T. Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation. Annu Rev Pharmacol Toxicol. 2009;49(1):123–150. doi: 10.1146/annurev.pharmtox.011008.145616. [DOI] [PubMed] [Google Scholar]
  • 50.Yen H.-W., Hu I.-C., Chen C.-Y., Ho S.-H., Lee D-J, Chang J.-S. Microalgae-based biorefinery–from biofuels to natural products. Bioresour Technol. 2013;135:166–174. doi: 10.1016/j.biortech.2012.10.099. [DOI] [PubMed] [Google Scholar]
  • 51.Kumar B.R., Deviram G., Mathimani T., Duc P.A., Pugazhendhi A. Microalgae as rich source of polyunsaturated fatty acids. Biocatal Agric Biotechnol. 2019;17:583–588. [Google Scholar]
  • 52.Lupette J., Benning C. Human health benefits of very-long-chain polyunsaturated fatty acids from microalgae. Biochimie. 2020;178:15–25. doi: 10.1016/j.biochi.2020.04.022. [DOI] [PubMed] [Google Scholar]
  • 53.Shanab S.M., Hafez R.M., Fouad A.S. A review on algae and plants as potential source of arachidonic acid. J Adv Res. 2018;11:3–13. doi: 10.1016/j.jare.2018.03.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Chauton M.S., Reitan K.I., Norsker N.H., Tveterås R., Kleivdal H.T. A techno-economic analysis of industrial production of marine microalgae as a source of EPA and DHA-rich raw material for aquafeed: research challenges and possibilities. Aquaculture. 2015;436:95–103. [Google Scholar]
  • 55.Bruno A., Rossi C., Marcolongo G., et al. Selective in vivo anti-inflammatory action of the galactolipid monogalactosyldiacylglycerol. Eur J Pharmacol. 2005;524(1–3):159–168. doi: 10.1016/j.ejphar.2005.09.023. [DOI] [PubMed] [Google Scholar]
  • 56.Ku C.S., Pham T.X., Park Y., et al. Edible blue-green algae reduce the production of pro-inflammatory cytokines by inhibiting NF-κb pathway in macrophages and splenocytes. Biochimica et Biophysica Acta (BBA)-General Subjects. 2013;1830(4):2981–2988. doi: 10.1016/j.bbagen.2013.01.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Simopoulos A.P. Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr. 1991;54(3):438–463. doi: 10.1093/ajcn/54.3.438. [DOI] [PubMed] [Google Scholar]
  • 58.Lee T.H., Hoover R.L., Williams J.D., et al. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. New England J Med. 1985;312(19):1217–1224. doi: 10.1056/NEJM198505093121903. [DOI] [PubMed] [Google Scholar]
  • 59.Adarme-Vega T.C., Lim D.K., Timmins M., Vernen F., Li Y., Schenk P.M. Microalgal biofactories: a promising approach towards sustainable omega-3 fatty acid production. Microb Cell Fact. 2012;11:1–10. doi: 10.1186/1475-2859-11-96. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Romieu I., Téllez-Rojo M.M., Lazo M., et al. Omega-3 fatty acid prevents heart rate variability reductions associated with particulate matter. Am J Respir Crit Care Med. 2005;172(12):1534–1540. doi: 10.1164/rccm.200503-372OC. [DOI] [PubMed] [Google Scholar]
  • 61.Calò L., Bianconi L., Colivicchi F., et al. N-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial. J Am Coll Cardiol. 2005;45(10):1723–1728. doi: 10.1016/j.jacc.2005.02.079. [DOI] [PubMed] [Google Scholar]
  • 62.Horrocks L.A., Yeo Y.K. Health benefits of docosahexaenoic acid (DHA) Pharmacol Res. 1999;40(3):211–225. doi: 10.1006/phrs.1999.0495. [DOI] [PubMed] [Google Scholar]
  • 63.David E., Niculescu V.-C. Volatile organic compounds (VOCs) as environmental pollutants: occurrence and mitigation using nanomaterials. Int J Environ Res Public Health. 2021;18(24) doi: 10.3390/ijerph182413147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Walsh K., Jones G.J., Dunstan R.H. Effect of high irradiance and iron on volatile odour compounds in the cyanobacterium microcystis aeruginosa. Phytochemistry. 1998;49(5):1227–1239. doi: 10.1016/s0031-9422(97)00943-6. [DOI] [PubMed] [Google Scholar]
  • 65.Santos A.B., Vieira K.R., Nogara G.P., Wagner R., Jacob-Lopes E., Zepka L.Q. Nova Science Publishers, Inc.; New York, NY, USA: 2016. Biogeneration of Volatile Organic Compounds by Microalgae: Occurrence, Behavior, Ecological Implications and Industrial Applications; pp. 1–24. [Google Scholar]
  • 66.Rowan D.D. Volatile metabolites. Metabolites. 2011;1(1):41–63. doi: 10.3390/metabo1010041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Achyuthan K.E., Harper J.C., Manginell R.P., Moorman M.W. Volatile metabolites emission by in vivo microalgae—An overlooked opportunity? Metabolites. 2017;7(3):39. doi: 10.3390/metabo7030039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Pozzer A.C., Gómez P.A., Weiss J. Volatile organic compounds in aquatic ecosystems–Detection, origin, significance and applications. Sci Total Environ. 2022;838 doi: 10.1016/j.scitotenv.2022.156155. [DOI] [PubMed] [Google Scholar]
  • 69.Zuo Z. Why algae release volatile organic compounds—The emission and roles. Front Microbiol. 2019;10:491. doi: 10.3389/fmicb.2019.00491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Rumchev K., Brown H., Spickett J. Volatile organic compounds: do they present a risk to our health? Rev Environ Health. 2007;22(1):39–56. doi: 10.1515/reveh.2007.22.1.39. [DOI] [PubMed] [Google Scholar]
  • 71.Mølhave L., Bach B., Pedersen O.F. Human reactions to low concentrations of volatile organic compounds. Environ Int. 1986;12(1–4):167–175. [Google Scholar]
  • 72.Zuo Z., Zhu Y., Bai Y., Wang Y. Acetic acid-induced programmed cell death and release of volatile organic compounds in Chlamydomonas reinhardtii. Plant Physiol Bioch. 2012;51:175–184. doi: 10.1016/j.plaphy.2011.11.003. [DOI] [PubMed] [Google Scholar]
  • 73.Vieira A.J., Beserra F.P., Souza M., Totti B., Limonene R.A. Aroma of innovation in health and disease. Chem Biol Interact. 2018;283:97–106. doi: 10.1016/j.cbi.2018.02.007. [DOI] [PubMed] [Google Scholar]
  • 74.Nörnberg M.L., Caetano P.A., Nass P.P., Vieira K.R., Wagner R., Jacob-Lopes E. Limonene production in microalgal photoautotrophic cultivation produção de limoneno em cultivo fotoautotrófico microalgal. Brazilian J Dev. 2022;8(2):10241–10254. [Google Scholar]
  • 75.Roberto D., Micucci P., Sebastian T., Graciela F., Anesini C. Antioxidant activity of limonene on normal murine lymphocytes: relation to H2O2 modulation and cell proliferation. Basic Clin Pharmacol Toxicol. 2010;106(1):38–44. doi: 10.1111/j.1742-7843.2009.00467.x. [DOI] [PubMed] [Google Scholar]
  • 76.Álvarez-Martínez F., Barrajón-Catalán E., Herranz-López M., Micol V. Antibacterial plant compounds, extracts and essential oils: an updated review on their effects and putative mechanisms of action. Phytomedicine. 2021;90 doi: 10.1016/j.phymed.2021.153626. [DOI] [PubMed] [Google Scholar]
  • 77.Costa M.D.S., Rocha J.E., Campina F.F., et al. Comparative analysis of the antibacterial and drug-modulatory effect of d-limonene alone and complexed with β-cyclodextrin. Eur J Pharmaceut Sci. 2019;128:158–161. doi: 10.1016/j.ejps.2018.11.036. [DOI] [PubMed] [Google Scholar]
  • 78.Zahi M.R., El Hattab M., Liang H., Yuan Q. Enhancing the antimicrobial activity of d-limonene nanoemulsion with the inclusion of ε-polylysine. Food Chem. 2017;221:18–23. doi: 10.1016/j.foodchem.2016.10.037. [DOI] [PubMed] [Google Scholar]
  • 79.Zhao Y., Bai M., Qiu D., et al. Comparative evaluation of sensory and instrumental flavor profiles of four edible microalgae: spirulina platensis, chlorella pyrenoidosa, chlamydomonas reinhardtii, and haematococcus pluvialis. Algal Res. 2024;82 [Google Scholar]
  • 80.Chen H., Yang R., Chen J., et al. 1-Octen-3-ol, a self-stimulating oxylipin messenger, can prime and induce defense of marine alga. BMC Plant Biol. 2019;19:1–16. doi: 10.1186/s12870-019-1642-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Sun S.-M., Chung G.-H., Shin T.-S. Volatile compounds of the green alga, capsosiphon fulvescens. J Appl Phycol. 2012;24:1003–1013. [Google Scholar]
  • 82.Lafarge C., Cayot N. Insight on a comprehensive profile of volatile compounds of chlorella vulgaris extracted by two “green” methods. Food Sci Nutr. 2019;7(3):918–929. doi: 10.1002/fsn3.831. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Xiong C., Li Q., Li S., Chen C., Chen Z., Huang W. In vitro antimicrobial activities and mechanism of 1-octen-3-ol against food-related bacteria and pathogenic fungi. J Oleo Sci. 2017;66(9):1041–1049. doi: 10.5650/jos.ess16196. [DOI] [PubMed] [Google Scholar]
  • 84.Moran L., Bou G., Aldai N., et al. Characterisation of the volatile profile of microalgae and cyanobacteria using solid-phase microextraction followed by gas chromatography coupled to mass spectrometry. Sci Rep. 2022;12(1):3661. doi: 10.1038/s41598-022-07677-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Lasta P., Vieira K.R., Pinheiro P.N., Wagner R., Zepka L.Q., Jacob-Lopes E. Volatile fraction and aroma properties of microalgae scenedesmus obliquus. Scientia Plena. 2021;17(8) [Google Scholar]
  • 86.Li S.-F., Zhang S.-B., Zhai H.-C., Lv Y.-Y., Hu Y.-S., Cai J.-P. Hexanal induces early apoptosis of Aspergillus flavus conidia by disrupting mitochondrial function and expression of key genes. Appl Microbiol Biotechnol. 2021;105:6871–6886. doi: 10.1007/s00253-021-11543-0. [DOI] [PubMed] [Google Scholar]
  • 87.Sanz C., Olias J.M., Perez A.G. Aroma biochemistry of fruits and vegetables. Phytochem Fruit Veg. 1997:125–156. [Google Scholar]
  • 88.Schwab W., Davidovich-Rikanati R., Lewinsohn E. Biosynthesis of plant-derived flavor compounds. Plant J. 2008;54(4):712–732. doi: 10.1111/j.1365-313X.2008.03446.x. [DOI] [PubMed] [Google Scholar]
  • 89.Guentert M. Springer; 2007. Flavours and Fragrances: Chemistry, Bioprocessing and Sustainability; pp. 1–14. in. [Google Scholar]
  • 90.Bacanlı M., Başaran A.A., Başaran N. Elsevier; 2018. Polyphenols: Prevention and Treatment of Human Disease; pp. 419–424. in. [Google Scholar]
  • 91.Hirota R., Roger N.N., Nakamura H., Song H.S., Sawamura M., Suganuma N. Anti-inflammatory effects of limonene from yuzu (Citrus junos Tanaka) essential oil on eosinophils. J Food Sci. 2010;75(3):H87–H92. doi: 10.1111/j.1750-3841.2010.01541.x. [DOI] [PubMed] [Google Scholar]
  • 92.Noordermeer M.A., Van Der Goot W., Van Kooij A.J., Veldsink J.W., Veldink G.A., Vliegenthart J.F. Development of a biocatalytic process for the production of C6-aldehydes from vegetable oils by soybean lipoxygenase and recombinant hydroperoxide lyase. J Agric Food Chem. 2002;50(15):4270–4274. doi: 10.1021/jf0202685. [DOI] [PubMed] [Google Scholar]
  • 93.Mau J.-L., Chyau C.-C., Li J.-Y., Tseng Y.-H. Flavor compounds in straw mushrooms volvariella volvacea harvested at different stages of maturity. J Agric Food Chem. 1997;45(12):4726–4729. [Google Scholar]
  • 94.Chen M. Chlorophyll modifications and their spectral extension in oxygenic photosynthesis. Annu Rev Biochem. 2014;83(1):317–340. doi: 10.1146/annurev-biochem-072711-162943. [DOI] [PubMed] [Google Scholar]
  • 95.Varela J.C., Pereira H., Vila M., León R. Production of carotenoids by microalgae: achievements and challenges. Photosyn. Res. 2015;125:423–436. doi: 10.1007/s11120-015-0149-2. [DOI] [PubMed] [Google Scholar]
  • 96.Koller M., Muhr A., Braunegg G. Microalgae as versatile cellular factories for valued products. Algal Res. 2014;6:52–63. [Google Scholar]
  • 97.Demmig-Adams B., Adams W.W., III Antioxidants in photosynthesis and human nutrition. Science (1979) 2002;298(5601):2149–2153. doi: 10.1126/science.1078002. [DOI] [PubMed] [Google Scholar]
  • 98.Guerin M., Huntley M.E., Olaizola M. Haematococcus astaxanthin: applications for human health and nutrition. Trends Biotechnol. 2003;21(5):210–216. doi: 10.1016/S0167-7799(03)00078-7. [DOI] [PubMed] [Google Scholar]
  • 99.Gong M., Bassi A. Carotenoids from microalgae: a review of recent developments. Biotechnol Adv. 2016;34(8):1396–1412. doi: 10.1016/j.biotechadv.2016.10.005. [DOI] [PubMed] [Google Scholar]
  • 100.Palozza P., Krinsky N.I. [38]Antioxidant effects of carotenoids in Vivo and in Vitro: an overview. Meth. Enzymol. 1992;213:403–420. doi: 10.1016/0076-6879(92)13142-k. [DOI] [PubMed] [Google Scholar]
  • 101.Naguib Y.M. Antioxidant activities of astaxanthin and related carotenoids. J Agric Food Chem. 2000;48(4):1150–1154. doi: 10.1021/jf991106k. [DOI] [PubMed] [Google Scholar]
  • 102.El-Agamey A., Lowe G.M., McGarvey D.J., et al. Carotenoid radical chemistry and antioxidant/pro-oxidant properties. Arch Biochem Biophys. 2004;430(1):37–48. doi: 10.1016/j.abb.2004.03.007. [DOI] [PubMed] [Google Scholar]
  • 103.Hu J., Nagarajan D., Zhang Q., Chang J.-S., Lee D-J. Heterotrophic cultivation of microalgae for pigment production: a review. Biotechnol Adv. 2018;36(1):54–67. doi: 10.1016/j.biotechadv.2017.09.009. [DOI] [PubMed] [Google Scholar]
  • 104.Goto S., Kogure K., Abe K., et al. Efficient radical trapping at the surface and inside the phospholipid membrane is responsible for highly potent antiperoxidative activity of the carotenoid astaxanthin. Biochimica et Biophysica acta (BBA)-Biomembranes. 2001;1512(2):251–258. doi: 10.1016/s0005-2736(01)00326-1. [DOI] [PubMed] [Google Scholar]
  • 105.Todd Miller M., Lavie C.J., White C.J. Impact of obesity on the pathogenesis and prognosis of coronary heart disease. J Cardiometab Syndr. 2008;3(3):162–167. doi: 10.1111/j.1559-4572.2008.00004.x. [DOI] [PubMed] [Google Scholar]
  • 106.Kurniawan R., Nurkolis F., Taslim N.A., et al. Carotenoids composition of green algae caulerpa racemosa and their antidiabetic, anti-obesity, antioxidant, and anti-inflammatory properties. Molecules. 2023;28(7):3267. doi: 10.3390/molecules28073267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 107.Seo Y.-J., Kim K.-J., Choi J., Koh E.-J., Lee B.-Y. Spirulina maxima extract reduces obesity through suppression of adipogenesis and activation of browning in 3T3-L1 cells and high-fat diet-induced obese mice. Nutrients. 2018;10(6):712. doi: 10.3390/nu10060712. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 108.Hsiao G., Chou P.-H., Shen M.-Y., Chou D-S, Lin C.-H., Sheu J.-R. C-phycocyanin, a very potent and novel platelet aggregation inhibitor from Spirulina platensis. J Agric Food Chem. 2005;53(20):7734–7740. doi: 10.1021/jf051352y. [DOI] [PubMed] [Google Scholar]
  • 109.Fung A., Hamid N., Lu J. Fucoxanthin content and antioxidant properties of Undaria pinnatifida. Food Chem. 2013;136(2):1055–1062. doi: 10.1016/j.foodchem.2012.09.024. [DOI] [PubMed] [Google Scholar]
  • 110.Yan X., Chuda Y., Suzuki M., Nagata T. Fucoxanthin as the major antioxidant in Hijikia fusiformis, a common edible seaweed. Biosci Biotechnol Biochem. 1999;63(3):605–607. doi: 10.1271/bbb.63.605. [DOI] [PubMed] [Google Scholar]
  • 111.Maeda H., Hosokawa M., Sashima T., Takahashi N., Kawada T., Miyashita K. Fucoxanthin and its metabolite, fucoxanthinol, suppress adipocyte differentiation in 3T3-L1 cells. Int J Mol Med. 2006;18(1):147–152. [PubMed] [Google Scholar]
  • 112.Maeda H., Hosokawa M., Sashima T., Funayama K., Miyashita K. Fucoxanthin from edible seaweed, undaria pinnatifida, shows antiobesity effect through UCP1 expression in white adipose tissues. Biochem Biophys Res Commun. 2005;332(2):392–397. doi: 10.1016/j.bbrc.2005.05.002. [DOI] [PubMed] [Google Scholar]
  • 113.Kozak L., Anunciado-Koza R. UCP1: its involvement and utility in obesity. Int J Obes. 2008;32(7):S32–S38. doi: 10.1038/ijo.2008.236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 114.Vermerris W., Nicholson R. Springer Science & Business Media; 2007. Phenolic Compound Biochemistry. [Google Scholar]
  • 115.Bravo L. Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev. 1998;56(11):317–333. doi: 10.1111/j.1753-4887.1998.tb01670.x. [DOI] [PubMed] [Google Scholar]
  • 116.Manach C., Mazur A., Scalbert A. Polyphenols and prevention of cardiovascular diseases. Curr Opin Lipidol. 2005;16(1):77–84. doi: 10.1097/00041433-200502000-00013. [DOI] [PubMed] [Google Scholar]
  • 117.Benavente-García O., Castillo J., Marin F.R., Ortuño A., Del Río J.A. Uses and properties of citrus flavonoids. J Agric Food Chem. 1997;45(12):4505–4515. [Google Scholar]
  • 118.Heim K.E., Tagliaferro A.R., Bobilya D.J. Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships. J Nutr Biochem. 2002;13(10):572–584. doi: 10.1016/s0955-2863(02)00208-5. [DOI] [PubMed] [Google Scholar]
  • 119.Servaites J.C., Faeth J.L., Sidhu S.S. A dye binding method for measurement of total protein in microalgae. Anal Biochem. 2012;421(1):75–80. doi: 10.1016/j.ab.2011.10.047. [DOI] [PubMed] [Google Scholar]
  • 120.Safi C., Charton M., Pignolet O., Silvestre F., Vaca-Garcia C., Pontalier P.-Y. Influence of microalgae cell wall characteristics on protein extractability and determination of nitrogen-to-protein conversion factors. J Appl Phycol. 2013;25:523–529. [Google Scholar]
  • 121.Seyfabadi J., Ramezanpour Z., Amini Khoeyi Z. Protein, fatty acid, and pigment content of chlorella vulgaris under different light regimes. J Appl Phycol. 2011;23:721–726. [Google Scholar]
  • 122.Becker E.W. Micro-algae as a source of protein. Biotechnol Adv. 2007;25(2):207–210. doi: 10.1016/j.biotechadv.2006.11.002. [DOI] [PubMed] [Google Scholar]
  • 123.Naik S.N., Goud V.V., Rout P.K., Dalai A.K. Production of first and second generation biofuels: a comprehensive review. Renew Sustain Energy Rev. 2010;14(2):578–597. [Google Scholar]
  • 124.Souza C.M.M., Bastos T.S., dos Santos M.C. Microalgae use in animal nutrition. Res, Society Dev. 2021;10(16) e53101622986-e53101622986. [Google Scholar]
  • 125.Takeda H. Classification of Chlorella strains by means of the sugar components of the cell wall. Biochem Syst Ecol. 1988;16(4):367–371. [Google Scholar]
  • 126.Takeda H. Classification of chlorella strains by cell wall sugar composition. Phytochemistry. 1988;27(12):3823–3826. [Google Scholar]
  • 127.Takeda H. Sugar composition of the cell wall and the taxonomy of chlorella (Chlorophyceae) 1. J Phycol. 1991;27(2):224–232. [Google Scholar]
  • 128.Blumreisinger M., Meindl D., Loos E. Cell wall composition of chlorococcal algae. Phytochemistry. 1983;22(7):1603–1604. [Google Scholar]
  • 129.Iwamoto H. Industrial production of microalgal cell-mass and secondary products-major industrial species: chlorella. Handbook Microal Culture: Biotechnol Appl Phycol. 2003:253–263. [Google Scholar]
  • 130.Hammann W., Ross A., Seames W. Sequential extraction of carbohydrates and lipids from chlorella vulgaris using combined physical and chemical pre-treatments. Chem Eng. 2024;8(1):11. [Google Scholar]
  • 131.Becker E.W. Vol. 10. Cambridge University Press; 1994. (Microalgae: Biotechnology and Microbiology). Vol. [Google Scholar]
  • 132.Patterson G.W. Sterols of some green algae. Compar Biochem Physiol Part B: Comparat Biochem. 1974;47(2):453–457. [Google Scholar]
  • 133.Ötleş S., Pire R. Fatty acid composition of Chlorella and spirulina microalgae species. J AOAC Int. 2001;84(6):1708–1714. [PubMed] [Google Scholar]
  • 134.HH Abdel-Baky, Shallan M., El-Baroty G., El-Baz F. Volatile compounds of the microalga Chlorella vulgaris and their phytotoxic effect. 2002 [Google Scholar]
  • 135.Muszyńska B., Krakowska A., Lazur J., et al. Bioaccessibility of phenolic compounds, lutein, and bioelements of preparations containing chlorella vulgaris in artificial digestive juices. J Appl Phycol. 2018;30:1629–1640. doi: 10.1007/s10811-017-1357-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 136.Wan Mahmood W.M.A., Lorwirachsutee A., Theodoropoulos C., Gonzalez-Miquel M. Polyol-based deep eutectic solvents for extraction of natural polyphenolic antioxidants from Chlorella vulgaris. ACS Sustain Chem Eng. 2019;7(5):5018–5026. [Google Scholar]
  • 137.Thangaraj M., Saravana B.P., Thanasekaran J., Joen-Rong S., Manubolu M., Pathakoti K. Phytochemicals of algae, arthospira platensis (spirulina) chlorella vulgaris (chlorella) and azolla pinnata (azolla) GSC Biol Pharmaceutical Sci. 2022;19(2):023–043. [Google Scholar]
  • 138.Pradhan B., Patra S., Dash S.R., Nayak R., Behera C., Jena M. Evaluation of the anti-bacterial activity of methanolic extract of chlorella vulgaris Beyerinck [Beijerinck] with special reference to antioxidant modulation. Futur J Pharm Sci. 2021;7:1–11. [Google Scholar]
  • 139.Wang H.-M., Pan J.-L., Chen C.-Y., et al. Identification of anti-lung cancer extract from Chlorella vulgaris CC by antioxidant property using supercritical carbon dioxide extraction. Process Biochem. 2010;45(12):1865–1872. [Google Scholar]
  • 140.El-Fayoumy E.A., Shanab S.M., Gaballa H.S., Tantawy M.A., Shalaby E.A. Evaluation of antioxidant and anticancer activity of crude extract and different fractions of chlorella vulgaris axenic culture grown under various concentrations of copper ions. BMC Complement Med Ther. 2021;21:1–16. doi: 10.1186/s12906-020-03194-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 141.Mashhadinejad A., Zamani H., Sarmad J. Effect of growth conditions and extraction solvents on enhancement of antimicrobial activity of the microalgae Chlorella vulgaris. Pharmaceutical Biomed Res. 2016;2(4):65–73. [Google Scholar]
  • 142.Syed S., Arasu A., Ponnuswamy I. The uses of Chlorella vulgaris as antimicrobial agent and as a diet: the presence of bio-active compounds which caters the vitamins, minerals in general. Int J Bio-Science Bio-Technol. 2015;7(1):185–190. [Google Scholar]
  • 143.Fathy R.R., Soliman R.A., El-Hadary A., Osman M., Magdy Y. Assessment of antiviral activity for ethanolic chlorella vulgaris extract against Newcastle Disease Virus (NDV) infection in Sasso chicken. J Appl Veterin Sci. 2023;8(2):67–79. [Google Scholar]
  • 144.Jayshree A., Jayashree S., Thangaraju N. Chlorella vulgaris and chlamydomonas reinhardtii: effective antioxidant, antibacterial and anticancer mediators. Indian J Pharm Sci. 2016;78(5):575–581. [Google Scholar]
  • 145.Sibi G., Rabina S. Inhibition of pro-inflammatory mediators and cytokines by Chlorella vulgaris extracts. Pharmacognosy Res. 2016;8(2):118. doi: 10.4103/0974-8490.172660. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 146.Regueiras A., Huguet Á., Conde T., et al. Potential anti-obesity, anti-steatosis, and anti-inflammatory properties of extracts from the microalgae chlorella vulgaris and chlorococcum amblystomatis under different growth conditions. Mar Drugs. 2021;20(1):9. doi: 10.3390/md20010009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 147.An H.-J., Rim H.-K., Lee J.-H., et al. Effect of chlorella vulgaris on immune-enhancement and cytokine production in vivo and in vitro. Food Sci Biotechnol. 2008;17(5):953–958. [Google Scholar]
  • 148.de Melo R.G., de Andrade A.F., Bezerra R.P., et al. Hydrogel-based chlorella vulgaris extracts: a new topical formulation for wound healing treatment. J Appl Phycol. 2019;31(6):3653–3663. [Google Scholar]
  • 149.Machmud E., Ruslin M., Waris R., Asse R.A., Qadafi A.M., Achmad H. Effect of the application of chlorella vulgaris ointment to the number of fibroblast cells as an indicator of wound healing in the soft tissue of pig ears. Pesquisa Brasileira em Odontopediatria e Clínica Integrada. 2020;20:e5012. [Google Scholar]
  • 150.Carlson M.A., Longaker M.T. The fibroblast-populated collagen matrix as a model of wound healing: a review of the evidence. Wound Repair Regenerat. 2004;12(2):134–147. doi: 10.1111/j.1067-1927.2004.012208.x. [DOI] [PubMed] [Google Scholar]
  • 151.Bainbridge P. Wound healing and the role of fibroblasts. J Wound Care. 2013;22(8):407–412. doi: 10.12968/jowc.2013.22.8.407. [DOI] [PubMed] [Google Scholar]
  • 152.Caicedo Y., Suarez C., Gelves G. Evaluation of preliminary plant design for Chlorella vulgaris microalgae production focused on cosmetics purposes. J Phys: Conf Series. 2020;1655 [Google Scholar]
  • 153.Ryu N.H., Lim Y., Park J.E., et al. Impact of daily Chlorella consumption on serum lipid and carotenoid profiles in mildly hypercholesterolemic adults: a double-blinded, randomized, placebo-controlled study. Nutr J. 2014;13:1–8. doi: 10.1186/1475-2891-13-57. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 154.Suetsuna K., Chen J.-R. Identification of antihypertensive peptides from peptic digest of two microalgae, Chlorella vulgaris and Spirulina platensis. Marine Biotechnology. 2001;3:305–309. doi: 10.1007/s10126-001-0012-7. [DOI] [PubMed] [Google Scholar]
  • 155.Xie J., Chen X., Wu J., et al. Antihypertensive effects, molecular docking study, and isothermal titration calorimetry assay of angiotensin I-converting enzyme inhibitory peptides from Chlorella vulgaris. J Agric Food Chem. 2018;66(6):1359–1368. doi: 10.1021/acs.jafc.7b04294. [DOI] [PubMed] [Google Scholar]
  • 156.National Center for Biotechnology Information. PubChem Compound Summary for CID 3893, Lauric Acid. https://pubchem.ncbi.nlm.nih.gov/compound/Lauric-Acid. Accessed May 20, 2025.
  • 157.National Center for Biotechnology Information. PubChem Compound Summary for CID 609844, 6,7-Dimethoxy-2-tetralone. https://pubchem.ncbi.nlm.nih.gov/compound/6_7-Dimethoxy-2-tetralone. Accessed on May 20, 2025.
  • 158.National Center for Biotechnology Information. PubChem Compound Summary for CID 5280435, Phytol. https://pubchem.ncbi.nlm.nih.gov/compound/Phytol. Accessed on May 20, 2025.
  • 159.National Center for Biotechnology Information. PubChem Compound Summary for CID 1781947, Isochavibetol. https://pubchem.ncbi.nlm.nih.gov/compound/Isochavibetol. Accessed on May 20, 2025.
  • 160.National Center for Biotechnology Information. PubChem Compound Summary for CID 5370028, 4-(6,6-Dimethyl-2-methylenecyclohex-3-enylidene)pentan-2-ol. https://pubchem.ncbi.nlm.nih.gov/compound/5370028. Accessed on May 20, 2025.
  • 161.National Center for Biotechnology Information. PubChem Compound Summary for CID 11005, Myristic Acid. https://pubchem.ncbi.nlm.nih.gov/compound/Myristic-Acid. Accessed on May 20, 2025.
  • 162.National Center for Biotechnology Information. PubChem Compound Summary for CID 100332, Loliolide. https://pubchem.ncbi.nlm.nih.gov/compound/Loliolide. Accessed on May 20, 2025.
  • 163.Rouse M.S., Rotger M., Piper K.E., et al. In vitro and in vivo evaluations of the activities of lauric acid monoester formulations against Staphylococcus aureus. Antimicrob. Agents Chemother. 2005;49(8):3187–3191. doi: 10.1128/AAC.49.8.3187-3191.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 164.Řiháková Z., Plocková M., Filip V., Šmidrkal J. Antifungal activity of lauric acid derivatives against Aspergillus niger. Eur Food Res Technol. 2001;213:488–490. [Google Scholar]
  • 165.Kato A., Ando K., Tamura G., Arima K. Effects of some fatty acid esters on the viability and transplantability of Ehrlich ascites tumor cells. Cancer Res. 1971;31(5):501–504. [PubMed] [Google Scholar]
  • 166.Calder P., Grimble R. Polyunsaturated fatty acids, inflammation and immunity. Eur J Clin Nutr. 2002;56(3):S14–S19. doi: 10.1038/sj.ejcn.1601478. [DOI] [PubMed] [Google Scholar]
  • 167.Saravanakumar D., Folb P., Campbell B., Smith P. Antimycobacterial activity of the red alga polysiphonia virgata. Pharm Biol. 2008;46(4):254–260. [Google Scholar]
  • 168.Villamor E., Koulinska I.N., Furtado J., et al. Long-chain n− 6 polyunsaturated fatty acids in breast milk decrease the risk of HIV transmission through breastfeeding. Am J Clin Nutr. 2007;86(3):682–689. doi: 10.1093/ajcn/86.3.682. [DOI] [PubMed] [Google Scholar]
  • 169.Vera W.J., Banerjee A.K. An efficient approach for the synthesis of 6, 7-dimethoxy-2-tetralone and 5, 6-dimethoxy-1-tetralone. Arkivoc. 2009;11:228–234. [Google Scholar]
  • 170.Inoue M., Yoshimi I., Sobue T., Tsugane S. Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan. J Natl Cancer Inst. 2005;97(4):293–300. doi: 10.1093/jnci/dji040. [DOI] [PubMed] [Google Scholar]
  • 171.Ogunlesi M., Okiei W., Osibote E., Muotoh C. Antimicrobial activity of the essential oil and the fractional samples obtained from the leaves and seeds of Phyllanthus amarus (Euphorbiaceae) Res J Phytochem. 2009;3(4):77–84. [Google Scholar]
  • 172.Sujatha B., Patel P. Moringa oleifera–nature’s gold. Imperial J Interdiscipl Res. 2017;3(5):1175–1179. [Google Scholar]
  • 173.Turner C.E., Elsohly M.A., Boeren E.G. Constituents of cannabis sativa L. XVII. A review of the natural constituents. J Nat Prod. 1980;43(2):169–234. doi: 10.1021/np50008a001. [DOI] [PubMed] [Google Scholar]
  • 174.White I., Johansen J.D., Arnau E.G., et al. Isoeugenol is an important contact allergen: can it be safely replaced with isoeugenyl acetate? Contact Derm. 1999;41(5):272–275. doi: 10.1111/j.1600-0536.1999.tb06160.x. [DOI] [PubMed] [Google Scholar]
  • 175.Sivakumar R., Jebanesan A., Govindarajan M., Rajasekar P. Oviposition attractancy of dodecanoic, hexadecanoic and tetradecanoic acids against Aedes aegypti and Culex quinquefasciatus (Diptera: culicidae) Eur Rev Med Pharmacol Sci. 2011;15(10):1172–1175. [PubMed] [Google Scholar]
  • 176.Diana H., Parthipan B. Compounds identification from hypersaline oscillatoria salina using GCMS– analysis. Int J Res Stud Biosci. 2015;3(9):6–10. [Google Scholar]
  • 177.Markkas N., Govindharajalu M. Determination of phytocomponents in the methanolic extract of Mollugo cerviana by GCMS– analysis. Int. J. Res. Biol. Sci. 2015;5(4):26–29. [Google Scholar]
  • 178.Chung C.-Y., Liu C.-H., Burnouf T., et al. Activity-based and fraction-guided analysis of Phyllanthus urinaria identifies loliolide as a potent inhibitor of hepatitis C virus entry. Antiviral Res. 2016;130:58–68. doi: 10.1016/j.antiviral.2016.03.012. [DOI] [PubMed] [Google Scholar]
  • 179.Grabarczyk M., Wińska K., Mączka W., Potaniec B., Anioł M. Loliolide-the most ubiquitous lactone. Acta universitatis lodziensis. Folia Biologica et Oecologica. 2015;11:1–8. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Data sharing is not applicable to this review article.


Articles from Integrative Medicine Research are provided here courtesy of Korea Institute of Oriental Medicine

RESOURCES